New substituted benzyl iminoether derivatives of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}(2)] (R = Me (1a, 2a), OMe (3a, 4a), F (5a, 6a)) have been synthesized and characterized by elemental analyses, FT-IR spectroscopy and NMR techniques. The iminoether ligands are in the E configuration, which is stable in solution and in the solid state, as confirmed by the H-1 NMR data. Complex trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}(2)] (6a) was also characterized by an X-ray diffraction study. Complexes 1 a-6a have been tested against a panel of human tumor cell lines in order to evaluate their cytotoxic activity. cis-Isomers were significant more potent than the corresponding trans-isomers against all tumor cell lines tested; moreover, complexes la and 5a showed IC50 values from about 2-fold to 6-fold lower than those exhibited by cisplatin, used as reference platinum anticancer drug. (C) 2007 Elsevier Inc. All rights reserved.

Synthesis, characterization and cytotoxic activity of substituted benzyl iminoether Pt(II) complexes of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}(2)] (R = Me, OMe, F). X-ray structure of trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}(2)]

Benetollo F;
2008

Abstract

New substituted benzyl iminoether derivatives of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}(2)] (R = Me (1a, 2a), OMe (3a, 4a), F (5a, 6a)) have been synthesized and characterized by elemental analyses, FT-IR spectroscopy and NMR techniques. The iminoether ligands are in the E configuration, which is stable in solution and in the solid state, as confirmed by the H-1 NMR data. Complex trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}(2)] (6a) was also characterized by an X-ray diffraction study. Complexes 1 a-6a have been tested against a panel of human tumor cell lines in order to evaluate their cytotoxic activity. cis-Isomers were significant more potent than the corresponding trans-isomers against all tumor cell lines tested; moreover, complexes la and 5a showed IC50 values from about 2-fold to 6-fold lower than those exhibited by cisplatin, used as reference platinum anticancer drug. (C) 2007 Elsevier Inc. All rights reserved.
2008
CHIMICA INORGANICA E DELLE SUPERFICI
Istituto di Chimica della Materia Condensata e di Tecnologie per l'Energia - ICMATE
Platinum antitumor drugs
cis-Configuration
Benzyliminoether ligands
PLATINUM ANTITUMOR COMPLEXES
COORDINATED NITRILES
CANCER-THERAPY
DRUGS
NMR
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/150541
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact